The State of Texas Attorney General Sues Tylenol Makers Regarding Autism Assertions

Texas Attorney General Ken Paxton is suing the makers of acetaminophen, asserting the corporations concealed safety concerns that the medication presented to children's cognitive development.

The lawsuit follows thirty days after President Donald Trump promoted an unproven link between consuming Tylenol - also known as paracetamol - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against the pharmaceutical giant, which once produced the drug, the sole analgesic recommended for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he stated they "deceived the public by making money from discomfort and marketing drugs without regard for the dangers."

The company says there is no credible evidence linking Tylenol to autism.

"These corporations misled for generations, intentionally threatening millions to boost earnings," the attorney general, a Republican, declared.

The company stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the well-being of American women and children."

On its online platform, the company also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that shows a proven link between taking paracetamol and autism spectrum disorder."

Groups acting on behalf of medical professionals and healthcare providers agree.

The leading OB-GYN organization has said acetaminophen - the main ingredient in acetaminophen - is one of the few options for expectant mothers to address pain and fever, which can create major wellness concerns if not addressed.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, no reliable research has conclusively proven that the consumption of acetaminophen in any trimester of pregnancy leads to neurological conditions in offspring," the group said.

The court filing mentions recent announcements from the former administration in claiming the medication is allegedly unsafe.

Last month, Trump raised alarms from public health officials when he advised expectant mothers to "struggle intensely" not to take acetaminophen when sick.

Federal regulators then released a statement that doctors should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the drug and autism in young ones has remains unverified.

Health Secretary RFK Jr, who manages the FDA, had pledged in spring to initiate "comprehensive study program" that would determine the origin of autism in a matter of months.

But authorities advised that finding a sole reason of autism - believed by scientists to be the consequence of a intricate combination of genetic and environmental factors - would not be simple.

Autism is a category of enduring cognitive variation and impairment that impacts how individuals encounter and interact with the surroundings, and is diagnosed using doctors' observations.

In his court filing, the attorney general - who supports Trump who is running for the Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The case aims to force the firms "remove any commercial messaging" that states acetaminophen is reliable for expectant mothers.

The court case parallels the concerns of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022.

A federal judge rejected the legal action, stating research from the parents' expert witnesses was not conclusive.